Couverture de At the Intersection of Science and Law

At the Intersection of Science and Law

At the Intersection of Science and Law

De : DLA Piper
Écouter gratuitement

À propos de ce contenu audio

 In DLA Piper’s At the Intersection of Science and Law podcast, members of the firm’s Life Sciences team explore the connection between science and the law in areas that include AI and drug discovery, mRNA technology, and the regulatory implications of new drugs and devices.2026 DLA Piper Science
Les membres Amazon Prime bénéficient automatiquement de 2 livres audio offerts chez Audible.

Vous êtes membre Amazon Prime ?

Bénéficiez automatiquement de 2 livres audio offerts.
Bonne écoute !
    Épisodes
    • Revolutionizing Clinical Trials: A discussion on diversity and patient-centric approaches

      Revolutionizing Clinical Trials: A discussion on diversity and patient-centric approaches
      Nov 15 2024

      In this episode, Quest Diagnostics’ Adam Donat is joined by DLA Piper’s Kirsten Axelsen, Rachel Portman, and Jae Kim to discuss the increasing complexity and cost of clinical trials, new FDA guidance, innovative trial designs and tools, and what’s expected in the new year.

      See omnystudio.com/listener for privacy information.
      Afficher plus Afficher moins
      30 min
    • Life sciences companies and the risks posed by the mifepristone litigation

      Life sciences companies and the risks posed by the mifepristone litigation
      May 19 2023

      In this episode, a cross-disciplinary team of FDA regulatory lawyers and life sciences litigators discuss the implications of the mifepristone litigation for life sciences companies as it pertains to citizen petitions, FDA approvals, and strategies manufacturers might consider going forward.

      See omnystudio.com/listener for privacy information.
      Afficher plus Afficher moins
      33 min
    • Trade secrets protection in the life sciences sector

      Trade secrets protection in the life sciences sector
      Apr 12 2023

      DLA Piper’s Roberto Valenti and Ray Miller discuss trade secrets protection in the US and Europe and the peculiarities within the life sciences sector. Our speakers provide pragmatic approaches and suggestions on how to manage trade secrets for both pharmaceutical companies and medical device manufacturers.

      See omnystudio.com/listener for privacy information.
      Afficher plus Afficher moins
      21 min
    Aucun commentaire pour le moment